Parkinson’s Disease Medications

100mg

Utilized to manage neurological symptoms, formulated to target movement disorders and to manage viral replication outcomes.

2mg

Indicated to support the reduction of tremors and muscle rigidity.

2.5mg

Utilized to target neurological conditions, this agent is indicated to support dopamine regulation and is formulated to alleviate symptoms associated with hormone imbalances.

0.25 · 0.5mg

Formulated to target prolactin levels and indicated to support hormonal balance, this dopamine agonist is utilized to manage endocrine disorders.

10/100 · 25/100 · 25/250 · 50/200mg

intended to manage parkinson's disease to address the loss of muscle control and motor symptoms.

5 · 10mg

Developed to support motor function in Parkinson's disease, utilized to target dopamine degradation and alleviate symptoms of neurological impairment.

0.125 · 0.25 · 0.5mg

Indicated to manage Parkinson's disease, this dopamine agonist is designed to alleviate motor symptoms and support movement control in affected individuals.

2.5mg

Indicated to support motor function in Parkinson's disease, utilized to alleviate symptoms by mimicking natural dopamine activity within the central nervous system.

0.25 · 0.5 · 1 · 2mg

Formulated to manage restless legs syndrome to support sleep quality.

0.25 · 0.5 · 1 · 2mg

indicated to manage parkinson's disease to support improved motor function and movement control.

10/100 · 25/100 · 25/250mg

Indicated to manage Parkinson's disease, this combination therapy is utilized to support motor function by replacing depleted dopamine in the central nervous system.

25/100mg

designed to alleviate motor dysfunction in Parkinson's disease through dopamine replenishment.

25/100/200mg

Utilized to manage neurological dysfunction to support motor control.

100mg

Developed to support motor control and indicated to alleviate symptoms of parkinsonian conditions.